| Title : AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19 - Good_2021_Antimicrob.Agents.Chemother_65_e02479 |
| Author(s) : Good SS , Westover J , Jung KH , Zhou XJ , Moussa A , La Colla P , Collu G , Canard B , Sommadossi JP |
| Ref : Antimicrobial Agents & Chemotherapy , 65 :e02479 , 2021 |
| Abstract : Good_2021_Antimicrob.Agents.Chemother_65_e02479 |
| ESTHER : Good_2021_Antimicrob.Agents.Chemother_65_e02479 |
| PubMedSearch : Good_2021_Antimicrob.Agents.Chemother_65_e02479 |
| PubMedID: 33558299 |
Good SS, Westover J, Jung KH, Zhou XJ, Moussa A, La Colla P, Collu G, Canard B, Sommadossi JP (2021)
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19
Antimicrobial Agents & Chemotherapy
65 :e02479
Good SS, Westover J, Jung KH, Zhou XJ, Moussa A, La Colla P, Collu G, Canard B, Sommadossi JP (2021)
Antimicrobial Agents & Chemotherapy
65 :e02479